Advertisement
In real-life conditions

Drug Survival Rates Highest for Ustekinumab for Pediatric Psoriasis

0
Drug survival rates higher than for adalimumab, etanercept for all treatment and psoriasis types
A contact lens-based drug delivery system is effective for therapeutic delivery of the antihistamine ketotifen

Contact Lens-Based Antihistamine Delivery Effective

0
Eyes wearing lenses with etafilcon A, ketotifen have lower mean itching scores than controls
Providing patients undergoing surgical procedures with an activated charcoal bag for opioid deactivation could increase appropriate opioid disposal

Receiving Activated Charcoal Bag Tied to Proper Opioid Disposal

0
Less medication flushing, inappropriate garbage disposal seen for those receiving activated charcoal bag
The drug artesunate -- the World Health Organization-recommended first-line treatment for severe malaria -- will become the first-line treatment for severe malaria in the United States

Guidance Lists New First-Line Treatment for Severe Malaria in the U.S.

0
With discontinuation of quinidine, IV artesunate is now first-line drug for treatment of malaria
Jatenzo (testosterone undecanoate)

FDA Grants Approval for Hypogonadism Treatment

0
Jatenzo indicated for men with low testosterone due to certain conditions
Adding docetaxel-based chemotherapy to standard treatment for high-risk nonmetastatic prostate cancer improves survival

Docetaxel Chemo Ups Survival in High-Risk Localized Prostate Cancer

0
Findings based on addition of docetaxel chemotherapy to androgen suppression, radiotherapy
Lifetime risks for hypertension under the American Heart Association and American College of Cardiology 2017 threshold exceed 75 percent for white men and African-American men and women

Lifetime HTN Risk High for Black Men and Women, White Men

0
Lifetime risks are higher under AHA/ACC 2017 HTN threshold than JNC7 threshold for hypertension
Cimzia (certolizumab pegol) injection has been approved to treat adults with nonradiographic axial spondyloarthritis with objective signs of inflammation

Cimzia Injection Approved for New Inflammatory Arthritis Indication

0
FDA grants approval for first treatment for nonradiographic axial spondyloarthritis
Taxane plus platinum regimens may be a reasonable alternative to doxorubicin plus cisplatin as postoperative adjuvant chemotherapy for endometrial cancer that carries a high risk for progression

Taxane + Platinum Feasible for Adjuvant Tx in Endometrial Cancer

0
Tolerability, survival similar to that for doxorubicin + cisplatin for postoperative adjuvant chemotherapy
Mayzent (siponimod) pills have been approved by the U.S. Food and Drug Administration for adults with relapsing multiple sclerosis.

FDA Approves Mayzent for Relapsing Multiple Sclerosis

0
Oral medication must be dispensed with important information about the drug's uses and risks